Table 1.
Demographic information for patients based on biopsy and radical prostatectomy (RP) histology.
| Age (y) | Serum PSA (ng/mL) | Pathological stage, n |
||||
|---|---|---|---|---|---|---|
| pT2 | pT3a | pT3b | ||||
| Biopsy | n = 151 | |||||
| Overall | 61 (55–66) | 6.5 (4.3–9.2) | ||||
| CaP status | Positive (n = 98) | 60.5 (55–65) | 6.4 (4.5–11) | |||
| Negative (n = 53) | 62 (55.75–68.25)NS | 6.5 (3.6–7.9)NS | ||||
| csCaP status | Present (n = 82) | 61 (55–66) | 6.75 (4.5–11.9) | |||
| Absent (n = 69) | 61 (55–67)NS | 6.0 (3.6–8.1)* | ||||
| RP | n = 60 | |||||
| Overall | 57 (54–64) | 6.15 (4.1–9.1) | ||||
| ISUP group | 1 (n = 2) | 56 (54–57) | 6.5 (4–9 ) | 2 | ||
| 2 (n = 30) | 57.5 (53–64) | 5.5 (4–7) | 26 | 3 | 1 | |
| 3 (n = 20) | 57 (55–61) | 7.3 (5–12) | 15 | 5 | ||
| 4 (n = 1) | 55 | 19 | 1 | |||
| 5 (n = 7) | 60 (55–68) | 10 (6–12) | 3 | 1 | 3 | |
| Primary/ tertiary pattern | ≥ 4 (n = 33) | 57 (55–64) | 7.3 (5–12) | 23 | 7 | 3 |
| 3 (n = 27) | 57 (51–63)NS | 5.4 (4–7)** | 25 | 2 | 1 | |
Median and interquartile range are shown for age and serum PSA. All comparisons were made using the Mann–Whitney U test (two-tailed).
* P < 0.05, ** P < 0.01.
CaP, prostate cancer; csCaP, clinically significant prostate cancer; ISUP, International Society of Urological Pathology; NS, not significant; PSA, prostate specific antigen.